The national birth defects prevention study: A review of the methods

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 103, Issue 8, 2015, Pages 656-669

  Reefhuis, Jennita ^a   Gilboa, Suzanne M ^a   Anderka, Marlene ^b   Browne, Marilyn L ^c,d   Feldkamp, Marcia L ^e   Hobbs, Charlotte A ^f   Jenkins, Mary M ^a   Langlois, Peter H ^g   Newsome, Kimberly B ^a   Olshan, Andrew F ^h   Romitti, Paul A ⁱ   Shapira, Stuart K ^a   Shaw, Gary M ^j   Tinker, Sarah C ^a   Honein, Margaret A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY AT ALBANY   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ UNIVERSITY OF IOWA   (United States)

^j STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Birth defects; Case control; Congenital anomalies; Epidemiology; Genetics; Methods; Pregnancy

Indexed keywords

ARTICLE; BRAIN MALFORMATION; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; EYE MALFORMATION; GASTROINTESTINAL MALFORMATION; HUMAN; INFANT; INFORMATION PROCESSING; INTERVIEW; LIMB MALFORMATION; LIVE BIRTH; MAJOR CLINICAL STUDY; METHODOLOGY; ORAL BIOPSY; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLE SIZE; STILLBIRTH; UNITED STATES; UROGENITAL TRACT MALFORMATION; CONGENITAL ABNORMALITIES; FEMALE; GENETIC MARKER; GENETIC PREDISPOSITION; HEALTH SURVEY; NEWBORN; NEWBORN SCREENING; PROCEDURES;

GENETIC MARKER;

CONGENITAL ABNORMALITIES; DATA COLLECTION; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; POPULATION SURVEILLANCE; UNITED STATES;

EID: 84939267172     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23384     Document Type: Article

References (29)

1. Botto LD, Lin AE, Riehle-Colarusso T, et al. 2007. Seeking causes: classifying and evaluating congenital hearts defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79:714-727.
2. Carmichael SL, Shaw GM, Yang W, et al. 2007. Maternal stressful life events and risks of birth defects. Epidemiology 18:356-361.
3. Centers for Disease Control and Prevention. 2008. Update on overall prevalence of major birth defects-Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 57:1-5.
4. Cogswell ME, Bitsko RH, Anderka M, et al. 2009. Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol 170:975-985.
5. Collins FS, Brooks LD, Chakravarti A. 1998. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 8:1229-1231.
6. Correa A, Gilboa SM, Besser LM, et al. 2008. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199:237 e231-239.
7. de Weerth C, Buitelaar JK. 2005. Physiological stress reactivity in human pregnancy-a review. Neurosci Biobehav Rev 29:295-312.
8. Gallagher ML, Sturchio C, Smith A, et al. 2011. Evaluation of mailed pediatric buccal cytobrushes for use in a case-control study of birth defects. Birth Defects Res A Clin Mol Teratol 91:642-648.
9. Garcia-Closas M, Egan KM, Abruzzo J, et al. 2001. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 10:687-696.
10. Glidewell J, Reefhuis J, Rasmussen SA, et al. 2013. Factors affecting maternal participation in the genetic component of the National Birth Defects Prevention Study - United States, 1997-2007. Genet Med 16:329-337.
11. Hansen D, Lou HC, Olsen J. 2000. Serious life events and congenital malformations: a national study with complete follow-up. Lancet 356:875-880.
12. Honein MA, Rasmussen SA, Reefhuis J, et al. 2007. Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology 18:226-233.
13. Jenkins MM, Reed-Gross E, Rasmussen SA, et al. 2009. Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A 149A:2378-2386.
14. Jenkins MM, Reed-Gross E, Barfield WD, et al. 2011. Qualitative assessment of study materials and communication strategies used in studies that include DNA collection. Am J Med Genet A 155:2721-2731.
15. Kielb C, Lin S, Herdt-Losavio M, et al. 2014. Maternal periconceptional occupational exposure to pesticides and selected musculoskeletal birth defects. Int J Hyg Environ Health 217:248-254.
16. Krakowiak P, Guan Y, Greenhaw J, et al. 2003. Quality of human DNA from buccal cytobrushes depends on storage conditions. Chicago, IL: University of Chicago Press. pp. 411.
17. Liberman RF, Stern JE, Luke B, et al. 2014. Validating assisted reproductive technology self-report. Epidemiology 25:773-775.
18. Lupo PJ, Langlois PH, Reefhuis J, et al. 2012. Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention Study. Environ Health Perspect 120:910-915.
19. MacLehose RF, Olshan AF, Herring AH, et al. 2009. Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology 20:27-35.
20. Miller DT, Adam MP, Aradhya S, et al. 2010. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749-764.
21. Nelson K, Holmes LB. 1989. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 320:19-23.
22. Rasmussen SA, Olney RS, Holmes LB, et al. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67:193-201.
23. Rocheleau CM, Lawson CC, Waters MA, et al. 2011. Inter-rater reliability of assessed prenatal maternal occupational exposures to solvents, polycyclic aromatic hydrocarbons, and heavy metals. J Occup Environ Hyg 8:718-728.
24. Srisukhumbowornchai S, Krikov S, Feldkamp ML. 2012. Self-reported maternal smoking during pregnancy by source in Utah, 2003-2007. Birth Defects Res A Clin Mol Teratol 94:996-1003.
25. Stingone JA, Luben TJ, Daniels JL, et al. 2014. Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the National Birth Defects Prevention Study. Environ Health Perspect 122:863-872.
26. Vissers LE, van Ravenswaaij CM, Admiraal R, et al. 2004. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36:955-957.
27. Waller DK, Shaw GM, Rasmussen SA, et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161:745-750.
28. Xu J, Kochanek KD, Murphy SL, Arias E. 2014. Mortality in the United States, 2012. NCHS Data Brief 168:1-8.
29. Yoon PW, Rasmussen SA, Lynberg MC, et al. 2001. The National Birth Defects Prevention Study. Public Health Rep 116(Suppl 1):32-40.